Beijing Airdoc Technology Co (HKSE:02251) Cash And Cash Equivalents : HK$977.6 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Beijing Airdoc Technology Co Cash And Cash Equivalents?

Beijing Airdoc Technology Co's quarterly cash and cash equivalents declined from Dec. 2022 (HK$1,583.78 Mil) to Jun. 2023 (HK$958.55 Mil) but then increased from Jun. 2023 (HK$958.55 Mil) to Dec. 2023 (HK$977.60 Mil).

Beijing Airdoc Technology Co's annual cash and cash equivalents declined from Dec. 2021 (HK$2,185.24 Mil) to Dec. 2022 (HK$1,583.78 Mil) and declined from Dec. 2022 (HK$1,583.78 Mil) to Dec. 2023 (HK$977.60 Mil).

Beijing Airdoc Technology Co Cash And Cash Equivalents Historical Data

The historical data trend for Beijing Airdoc Technology Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Airdoc Technology Co Cash And Cash Equivalents Chart

Beijing Airdoc Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

94.96

444.18

2,185.24

1,583.78

977.60

Beijing Airdoc Technology Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial				2,185.24	1,666.02	1,583.78	958.55	977.60

Beijing Airdoc Technology Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Beijing Airdoc Technology Co (HKSE:02251) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Beijing Airdoc Technology Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Beijing Airdoc Technology Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Airdoc Technology Co (HKSE:02251) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Beijing Airdoc Technology Co Ltd (HKSE:02251) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

West Third Ring North Road, Room 21, 4th Floor, Building 2, A2 Yard, Haidian District, Beijing, CHN

Website

https://www.airdoc.com

Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices and other services.

Executives

Mialkos Tomasz Jakub	2101 Beneficial owner
Zhang Dalei	2501 Other
Fosun Holdings Limited	2201 Interest of corporation controlled by you
Yadong Beichen Venture Investment Co., Ltd.	2101 Beneficial owner
Shanghai Ruikun Venture Capital Investment Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun Industrial Investment Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd.	2201 Interest of corporation controlled by you
Guo Guangchang	2201 Interest of corporation controlled by you
Fosun International Limited	2201 Interest of corporation controlled by you
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Chen Mingqiang	2501 Other
Gao Fei	2501 Other
Niagara Falls Holding Limited	2101 Beneficial owner
China Life Franklin Asset Management Co., Limited
China Life Insurance (group) Company

Beijing Airdoc Technology Co (HKSE:02251) Headlines

No Headlines